4//SEC Filing
Lee Tien-Li 4
Accession 0000950170-25-086147
CIK 0001774857other
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 4:05 PM ET
Size
5.4 KB
Accession
0000950170-25-086147
Insider Transaction Report
Form 4
Lee Tien-Li
DirectorChief Executive Officer10% Owner
Transactions
- Award
Stock option (right to buy)
2025-06-11+549,534→ 549,534 totalExercise: $11.29Exp: 2035-06-11→ Common Stock (549,534 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to the option shall vest on June 11, 2026, and 1/48th of the shares subject to the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service through each vesting date, inclusive.
Documents
Issuer
Aardvark Therapeutics, Inc.
CIK 0001774857
Entity typeother
Related Parties
1- filerCIK 0001940120
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 4:05 PM ET
- Size
- 5.4 KB